147 related articles for article (PubMed ID: 23813282)
1. Associations of baseline characteristics with evolution of eGFR in a referred chronic kidney disease cohort.
Hoefield RA; Kalra PA; Lane B; O'Donoghue DJ; Foley RN; Middleton RJ
QJM; 2013 Oct; 106(10):915-24. PubMed ID: 23813282
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
[TBL] [Abstract][Full Text] [Related]
3. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
Lambers Heerspink HJ; Tighiouart H; Sang Y; Ballew S; Mondal H; Matsushita K; Coresh J; Levey AS; Inker LA
Am J Kidney Dis; 2014 Dec; 64(6):860-6. PubMed ID: 25441439
[TBL] [Abstract][Full Text] [Related]
4. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
5. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
6. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
[TBL] [Abstract][Full Text] [Related]
7. Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study.
Tsai YC; Tsai JC; Chen SC; Chiu YW; Hwang SJ; Hung CC; Chen TH; Kuo MC; Chen HC
Am J Kidney Dis; 2014 Jan; 63(1):68-75. PubMed ID: 23896483
[TBL] [Abstract][Full Text] [Related]
8. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
9. Five-year decline in estimated glomerular filtration rate associated with a higher risk of renal disease and atherosclerotic vascular disease clinical events in elderly women.
Lim WH; Lewis JR; Wong G; Dogra GK; Zhu K; Lim EM; Dhaliwal SS; Prince RL
QJM; 2013 May; 106(5):443-50. PubMed ID: 23407347
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with kidney disease progression and mortality in a referred CKD population.
Hoefield RA; Kalra PA; Baker P; Lane B; New JP; O'Donoghue DJ; Foley RN; Middleton RJ
Am J Kidney Dis; 2010 Dec; 56(6):1072-81. PubMed ID: 20692750
[TBL] [Abstract][Full Text] [Related]
11. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent risk factors associated with the decline of estimated GFR in CKD patients.
Chang WX; Arai S; Tamura Y; Kumagai T; Ota T; Shibata S; Fujigaki Y; Shen ZY; Uchida S
Clin Exp Nephrol; 2016 Feb; 20(1):58-70. PubMed ID: 26100399
[TBL] [Abstract][Full Text] [Related]
13. Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?
Ferrari P; Xiao J; Ukich A; Irish A
Nephrol Dial Transplant; 2009 Jun; 24(6):1828-33. PubMed ID: 19131346
[TBL] [Abstract][Full Text] [Related]
14. A population-based approach for the definition of chronic kidney disease: the CKD Prognosis Consortium.
Cirillo M; Lombardi C; Mele AA; Marcarelli F; Bilancio G
J Nephrol; 2012; 25(1):7-12. PubMed ID: 22038337
[TBL] [Abstract][Full Text] [Related]
15. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
[TBL] [Abstract][Full Text] [Related]
16. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
[TBL] [Abstract][Full Text] [Related]
17. Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease.
Rosansky SJ
Am J Nephrol; 2012; 36(1):1-10. PubMed ID: 22699366
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease.
Panizo N; Goicoechea M; García de Vinuesa S; Arroyo D; Yuste C; Rincón A; Verdalles U; Ruiz-Caro C; Quiroga B; Luño J
Nefrologia; 2012; 32(2):197-205. PubMed ID: 22425799
[TBL] [Abstract][Full Text] [Related]
20. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study.
Baek SD; Baek CH; Kim JS; Kim SM; Kim JH; Kim SB
Scand J Urol Nephrol; 2012 Jun; 46(3):232-8. PubMed ID: 22545920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
